Related Experiment Video
Updated: Jul 2, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Tissue-Agnostic Cancer Therapy Approvals
Mohamed A Gouda1, Vivek Subbiah2
1Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 455, Houston, TX, USA.
Tumor-agnostic cancer therapy represents a major advance in precision oncology, shifting focus from tumor location to molecular characteristics. This approach offers new treatment possibilities for various cancer types by targeting specific genetic profiles.
Area of Science:
- Oncology
- Genetics
- Precision Medicine
Background:
- Conventional cancer treatments are categorized by tissue of origin.
- Tumor-agnostic therapy represents a paradigm shift in cancer treatment.
- This approach targets the molecular and genetic attributes of tumors.
Purpose of the Study:
- To provide a comprehensive review of current tissue-agnostic cancer therapies.
- To offer clinical insights for surgical oncologists.
- To deepen understanding of innovative therapeutic strategies.
Main Methods:
- Review of current literature on tumor-agnostic therapies.
- Analysis of clinical applications and outcomes.
- Synthesis of information for surgical oncology practice.
Main Results:
- Tumor-agnostic therapies are defined by molecular targets, not histology.
- These therapies offer a new avenue for precision oncology.
- Understanding these approaches is crucial for surgical oncologists.
Conclusions:
- Tumor-agnostic cancer therapy is a significant evolution in oncology.
- It enables treatments based on genetic profiles, transcending traditional classifications.
- This review equips surgical oncologists with essential knowledge of these advanced therapies.
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

